Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guerin in South Korea

被引:31
|
作者
Neuenschwander, BE
Zwahlen, M
Kim, SJ
Lee, EG
Rieder, HL
机构
[1] Fed Off Publ Hlth, Bern, Switzerland
[2] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland
[3] Korean Inst TB, Seoul, South Korea
[4] Int Union TB & Lung Dis, Paris, France
关键词
Bayes theorem; BCG vaccine; mixture model; Mycobacterium bovis; prevalence; tuberculin test; tuberculosis;
D O I
10.1093/aje/155.7.654
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prevalence of tuberculous infection was estimated among 12,032 persons with a Bacillus Calmette-Guerin (BCG) vaccination scar and 7,788 persons without such a scar who participated in a nationwide tuberculin skin test survey conducted in the Republic of Korea in 1975. The analysis was built upon mixture models that captured the heterogeneity of indurations arising from tuberculous infection, cross-reactions due to infection with environmental mycobacteria, and BCG vaccination. The three distributions were allowed to vary by age, sex, and BCG vaccination status in the Bayesian manner, according to the prior opinion of the authors. Estimated prevalences of tuberculous infection were similar among persons with a BCG scar and persons without one: 7.5% (95% credibility interval (CI): 3.1, 12.5) and 5.2% (95% CI: 4.2, 6.3), respectively, at age 0-4 years and 87.3% (95% CI: 84.0, 90.2) and 84.0% (95% CI: 81.9, 85.8), respectively, at age 25-29 years. From this analysis it can be concluded that mixture models allow investigators, for the first time, to estimate the prevalence of tuberculous infection not only in unvaccinated persons but also in the BCG-vaccinated population. Mixture models are a versatile tool for analyzing diagnostic test data and more general classification problems of considerable complexity.
引用
收藏
页码:654 / 663
页数:10
相关论文
共 50 条
  • [41] Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection
    Jiang Pi
    Zhiyi Zhang
    Enzhuo Yang
    Lingming Chen
    Lingchan Zeng
    Yiwei Chen
    Richard Wang
    Dan Huang
    Shuhao Fan
    Wensen Lin
    Hongbo Shen
    Jun-Fa Xu
    Gucheng Zeng
    Ling Shen
    Journal of Nanobiotechnology, 20
  • [42] Lower hookworm incidence, prevalence, and intensity of infection in children with a bacillus Calmette-Guerin vaccination scar
    Barreto, ML
    Rodrigues, LC
    Silva, RCR
    Assis, AMO
    Reis, MG
    Santos, CAST
    Blanton, RE
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06): : 1800 - 1803
  • [43] A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guerin (BCG) against Mycobacterium tuberculosis
    Maurya, Sudeep Kumar
    Aqdas, Mohammad
    Das, Deepjyoti Kumar
    Singh, Sanpreet
    Nadeem, Sajid
    Kaur, Gurpreet
    Agrewala, Javed Naim
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [44] Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette-Guerin (BCG) immunotherapy
    Meyer, Ryan K.
    Williams, Stephen J.
    Lee, Thomas Y.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2020, 19
  • [45] Infection model of the human retinal pigment epithelium cell line ARPE-19 by Mycobacterium tuberculosis complex bacillus Calmette-Guerin
    Llorens, Victor
    Molins, Blanca
    Mesquida, Marina
    Sainz De La Maza, Maite
    Zarranz-Ventura, Javier
    Sala-Puigdollers, Anna
    Gonzalez-Martin, Julian
    Adan Civera, Alfredo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [46] Interferon-αβ mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection
    Kuchtey, J
    Fulton, SA
    Reba, SM
    Harding, CV
    Boom, WH
    IMMUNOLOGY, 2006, 118 (01) : 39 - 49
  • [47] Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Guerin against tuberculosis
    Feng, CG
    Palendira, U
    Demangel, C
    Spratt, JM
    Malin, AS
    Britton, WJ
    INFECTION AND IMMUNITY, 2001, 69 (06) : 4174 - 4176
  • [48] Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains
    Hayashi, Daisuke
    Takii, Takemasa
    Fujiwara, Nagatoshi
    Fujita, Yukiko
    Yano, Ikuya
    Yamamoto, Saburo
    Kondo, Maki
    Yasuda, Emi
    Inagaki, Emi
    Kanai, Keita
    Fujiwara, Akiko
    Kawarazaki, Aya
    Chiba, Taku
    Onozaki, Kikuo
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2009, 56 (02): : 116 - 128
  • [49] Protective Effect Of The Bacillus Calmette-Guerin Vaccine Against Tuberculosis Disease Among Health Care Workers Of A Peruvian University Hospital
    Lopez, L. M.
    Wang, J. -D. Ju
    Mayorga Huallpa, V. S.
    Alegre, M.
    Xu, C. M. Zhang
    Accinelli, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [50] IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guerin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice
    Dwivedi, Varun
    Gautam, Shalini
    Headley, Colwyn A.
    Piergallini, Tucker
    Torrelles, Jordi B.
    Turner, Joanne
    JOURNAL OF IMMUNOLOGY, 2022, 208 (06): : 1406 - 1416